Usability and Acceptability of the Abatacept Pre-Filled Autoinjector for the Subcutaneous Treatment of Rheumatoid Arthritis
Conclusion
The abatacept autoinjector demonstrated usability without patterns of preventable use errors, and with high acceptability ratings across all key attributes assessed. Preference over competitor autoinjectors was due to device ergonomics, visualization of dose progression, confidence of dose delivery, and overall ease of use.
Funding
Bristol-Myers Squibb.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Abatacept | Arthritis | Drugs & Pharmacology | Men | Orencia | Rheumatoid Arthritis | Rheumatology | Skin | Study